GC Aesthetics, Inc. (GCA) is a private medical technology company that provides women’s medical aesthetics and cosmetic solutions. The company today announced growth and expansion plans in the Brazilian market. Brazil is the second-largest breast augmentation market in the world.
GC Aesthetics has been executing an ambitious plan to reposition its brand and product portfolio to offer a smart, unique, and clinically proven line of safe products catering to Brazilian women and surgeons.
GC Aesthetics sources added that its Brazilian Development Module and Expansion strategy comprises two core pillars: – the first is to drive the commercialization of all GC Aesthetics merchandise and solutions designed to assist women in achieving the desired results before, after, and during breast augmentation surgery. This unique product portfolio not only stands out in today’s industry but is in line with the company’s leadership and growth plans to transform from a breast implant manufacturer to a solutions provider.
Further GC Aesthetics stated that the revenue growth of the firm in Brazil is also related to the newly obtained ANVISA certificate (Brazilian Health Supervision Agency). The company takes this opportunity to re-launch The Round Collection breast implants. This unique micro-textured surface breast implant has long been the first choice of Brazilian surgeons: 99% of plastic surgeons surveyed rated The Round Collection as a product they can trust in terms of safety and efficacy.
Carlos Reis Pinto, CEO of GC Aesthetics, stated: “According to our latest survey, proven safety and unique microtexture types are two of the top reasons Brazilian plastic surgeons prefer The Round Collection implants over the competition. Why. We are very excited to bring this product back to Brazil to provide surgeons and patients with a long-term proven, safe, and reliable medical device. Pre-orders for this product have exceeded our expectations and we look forward to having it in Brazil and around the world A very bright and dominant future.”
Ron Cosmas, Chief Commercial Officer of GCA, commented: “At GCA, they are committed to advancing the medical aesthetic sciences and delivering clinical, operational, and commercial excellence to be the partner of choice for surgeons and physicians around the world. Excited for the Round Collection to re-enter the Brazilian market and delighted to present our brand as a ‘unified GCA.”
The firm further declared that the product’s re-launch will be at the Jornada Paulista de Cirurgia Plástica conference, June 15-18 at the World Trade Center in Sao Paulo, Brazil. The Round Collection breast implants are designed for performance with unmatched long-term safety.
Industry sources added that the Round Collection by GC Aesthetics participated in the largest long-term clinical study of breast implants in Europe and achieved excellent results over a 10-year study period. The study also recently published a unique 17-year patient follow-up with high patient satisfaction.
